FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for the differential diagnosis of infectious mononucleosis of Epstein-Barr viral etiology, acute bacterial tonsillitis and acute viral hepatitis "B" in adults. Comprehensive study of the patient’s blood factors and differentiation of the diseases in case of certain deviations relative to the norm of values of patient’s blood factors has been proposed.
EFFECT: method allows to simplify and accelerate the differential diagnosis.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIAL EXPRESS DIAGNOSTICS OF ACUTE VIRAL AND BACTERIAL INFECTIONS | 2015 |
|
RU2602677C1 |
| METHOD FOR INFECTIOUS MONONUCLEOSIS SEVERITY DIAGNOSTICS | 2017 |
|
RU2638801C1 |
| DIAGNOSTIC TECHNIQUE OF SEVERITY OF EPSTEIN-BARR VIRUS INDUCED ACUTE INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2011 |
|
RU2471196C1 |
| METHOD OF CLINICAL OUTCOME FORECAST OF ACUTE VIRAL HEPATITIS B | 2007 |
|
RU2325656C1 |
| METHOD FOR PREDICTING THE FLOW OF INFECTIOUS MONONUCLEOSIS CAUSED WITH EPSTEIN-BARR VIRUS IN CHILDREN | 2005 |
|
RU2285262C1 |
| METHOD FOR EARLY PREDICTION OF CLINICAL OUTCOME OF ANTIVIRAL THERAPY FOR CHRONIC VIRAL HEPATITIS C | 2011 |
|
RU2480526C2 |
| METHOD OF ASSESSING THE SEVERITY OF ACUTE INFECTIOUS MONONUCLEOSIS CAUSED BY THE EPSTEIN-BARR VIRUS IN CHILDREN | 2022 |
|
RU2798079C1 |
| METHOD FOR DIAGNOSING THE SEVERITY OF EPSTEIN-BARR VIRUS-INDUCED ACUTE INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2022 |
|
RU2797960C1 |
| METHOD FOR SEVERITY DETERMINATION FOR ACUTE INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN - BARR VIRUS IN CHILDREN | 2016 |
|
RU2625505C1 |
| METHOD OF DETERMINING PROINFLAMMATORY AND PROALLERGIC INTERLEUKINS IN NASAL SECRETION IN INFANTS AND PRESCHOOL CHILDREN FOR DIAGNOSTICS OF AETIOLOGY OF RECURRING ACUTE RHINOPHARYNGITIS AND ADENOIDITIS | 2013 |
|
RU2569054C2 |
